Literature DB >> 9626986

Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry.

A C Matzdorff1, G Kühnel, B Kemkes-Matthes, H Pralle.   

Abstract

With fluorescent beads it has become possible to determine absolute numbers of cells in a given sample instead of relative percentages on a standard flow cytometer. This study assesses the ability to count platelets, microparticles, and aggregates with a flow cytometer. Whole blood was stimulated with 0.1 U thrombin per milliliter. Platelet and microparticle counts decreased, while the number of aggregates increased. Unactivated whole blood was diluted with buffer and showed a corresponding decrease in the concentration of platelets, microparticles, and aggregates. The platelet count on the flow cytometer was always in good correlation with counts on an automated blood analyzer. Only the cytometer, and not the automated analyzer, was able to detect and count microparticles and aggregates. In highly diluted samples of unactivated whole blood there was a spurious relative increase in CD62p-positive platelets because of a surplus of anti-CD62p antibodies and a relative increase in microparticles. Flow cytometry is a valuable method for counting platelets, aggregates, and microparticles in unstimulated and activated blood samples. If the platelet count changes and drops to less than 50% of the count for which the amount of antibody and the cytometer settings have initially been adjusted, care has to be taken to avoid misinterpretation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626986     DOI: 10.1016/s0022-2143(98)90059-2

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

Review 1.  Function and clinical significance of platelet-derived microparticles.

Authors:  S Nomura
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

2.  Activation of blood platelets in echinococcosis--CD62P and CD63 expression.

Authors:  Joanna Matowicka-Karna; Halina Kemona; Violetta Dymicka-Piekarska; Anna Butkiewicz
Journal:  Parasitol Res       Date:  2005-12-07       Impact factor: 2.289

3.  Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer.

Authors:  A C Matzdorff; G Kühnel; B Kemkes-Matthes; R Voss
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

Review 4.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

5.  Platelet Defects in Acute Myeloid Leukemia-Potential for Hemorrhagic Events.

Authors:  Horia Bumbea; Ana Maria Vladareanu; Ion Dumitru; Viola Maria Popov; Cristina Ciufu; Anca Nicolescu; Minodora Onisai; Cristina Marinescu; Diana Cisleanu; Irina Voican; Sinziana Sarghi
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

6.  Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.

Authors:  Kim L L Habets; Leendert A Trouw; E W Nivine Levarht; Suzanne J A Korporaal; Petra A M Habets; Philip de Groot; Tom W J Huizinga; René E M Toes
Journal:  Arthritis Res Ther       Date:  2015-08-24       Impact factor: 5.156

7.  Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients.

Authors:  Sascha Marx; Maximilian Splittstöhser; Frederik Kinnen; Eileen Moritz; Christy Joseph; Sebastian Paul; Heiko Paland; Carolin Seifert; Madlen Marx; Andreas Böhm; Edzard Schwedhelm; Kerstin Holzer; Stephan Singer; Christoph A Ritter; Sandra Bien-Möller; Henry W S Schroeder; Bernhard H Rauch
Journal:  Oncotarget       Date:  2018-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.